AI Steps Deeper Into Finance as Interactive Brokers Launches Portfolio Assistant In a fresh demonstration of artificial intelligence’s growing foothold…
Key Highlights: ARCHER Phase II Trial Design and Topline Results Cardiol Therapeutics’ ARCHER trial was a multi-national, randomized, double-blind, placebo-controlled…